View Post

FDA chief outlines new ways to speed cancer drug approvals

In In The News by Barbara Jacoby

By: Julie Steenhuysen From: The U.S. Food and Drug Administration is taking steps to streamline the approval process for cancer drugs, reviewing clinical trial data up front to make sure applications companies submit are complete. The new approach, outlined on Saturday in a speech by FDA commissioner Dr. Scott Gottlieb at the American Society of Clinical Oncology (ASCO) meeting in …